A pseudopeptide platform with side chains addressable for combinatorial applications

Tetrahedron Letters

Volumn 40, Issue 18, 1999, Pages 3511-3514

  Rasmussen, Palle H ^a   Rebek Jr , Julius ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Combinatorial chemistry; Orthogonal protection; Peptidomimetic; Platform

Indexed keywords

PSEUDOPEPTIDE;

ARTICLE; CATALYSIS; CHEMICAL ANALYSIS; CHEMICAL MODIFICATION; CHEMICAL STRUCTURE; CONFORMATIONAL TRANSITION; HYDROGEN BOND; STRUCTURE ACTIVITY RELATION; SYNTHESIS;

EID: 0033617124     PISSN: 00404039     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0040-4039(99)00544-4     Document Type: Article

References (31)

1. 1 Kocis, P.; Issakova, O.; Sepetov, N. F.; Lebl, M. Tetrahedron Lett. 1995, 36(37), 6623-6626.
2. 2 a) Araki, K.; Inada, K.; Shinkai, S. Angew. Chem. Int. Ed. Engl. 1996, 35, 72-74.
3. b) Bisson, A.; Lynch, V.M.; Monahan M-K. C.; Anslyn E. V. Angew. Chem. Int. Ed. Engl. 1997, 36, 2340-2342.
4. c) Pieters, R.J.; Cuntze, J.; Bonnet, M.; Diederich, F. J. Chem. Soc., Perkin Trans. 2. 1997, 1891-1900.
5. 3 Similar functionalized oxazole-based platforms are only available in 25 mg quantities. Mink, D.; Mecozzi, S.; Rebek, J., Jr. Tetrahedron Lett. 1998, 39, 5709-5712.
6. 4 Ishida and coworkers have reported cyclic peptides with similar backbones but without functionalized side chains, a) Ishida, H.; Donowaki, K.; Suga, M.; Shirnose, K.; Ohkubo, K. Tetrahedron Lett. 1995, 36(49), 8987-8990. b) Ishida, H.; Suga, M.; Donowaki, K.; Ohkubo, K. J. Org. Chem. 1995, 60, 5376-5375.
7. 4 Ishida and coworkers have reported cyclic peptides with similar backbones but without functionalized side chains, a) Ishida, H.; Donowaki, K.; Suga, M.; Shirnose, K.; Ohkubo, K. Tetrahedron Lett. 1995, 36(49), 8987-8990. b) Ishida, H.; Suga, M.; Donowaki, K.; Ohkubo, K. J. Org. Chem. 1995, 60, 5376-5375.
8. 5 Mohamadi, F.; Richards, N. G. J.; Guida, W. C.; Liskamp, R.; Caufield, C.; Chang, G.; Hendrickson, T.; Still, C. W. J. Comput. Chem. 1990, 11, 440-467.
9. 6 Allinger, N. L. J. Am. Chem. Soc. 1977, 99, 8127-8134.
10. 7 Waldvogel, S. R.; Wartini, A.; Rasmussen, P. H.; Rebek, J., Jr. Tetrahedron Lett. Submitted.
11. 8 For recent examples see: a) Metzger, A.; Anslyn, E. V. Angew. Chem. Int. Ed. 1998, 37, 649-652. b) Cohen, S. M.; Meyer M.; Raymond K. M. J. Am. Chem. Soc. 1998, 120, 6277-6286.
12. 8 For recent examples see: a) Metzger, A.; Anslyn, E. V. Angew. Chem. Int. Ed. 1998, 37, 649-652. b) Cohen, S. M.; Meyer M.; Raymond K. M. J. Am. Chem. Soc. 1998, 120, 6277-6286.
13. 9 For recent rewievs see: a) Timmerman, P.; Verbom, W.; Reinhoudt, D. N. Tetrahedron 1996, 52, 2663-2704. b) Higler, I.; Timmerman, P.; Verbom, W.; Reinhoudt, D. N. Eur. J. Org. Chem. 1998, 2689-2702.
14. 9 For recent rewievs see: a) Timmerman, P.; Verbom, W.; Reinhoudt, D. N. Tetrahedron 1996, 52, 2663-2704. b) Higler, I.; Timmerman, P.; Verbom, W.; Reinhoudt, D. N. Eur. J. Org. Chem. 1998, 2689-2702.
15. 10 Hamuro, Y.; Calama, M. C.; Park, H. S.; Hamilton, A. D. Angew. Chem. Ed. Engl. 1997, 36, 2680-2683.
16. 11 For recent examples see: a) Jagessar, R.; Burns, D. H. Chem. Commun. 1997, 1685-1686. b) Collman, J.P.; Wang, Z.; Straumanis, A. J. Org. Chem. 1998, 63, 2424-2425.
17. 11 For recent examples see: a) Jagessar, R.; Burns, D. H. Chem. Commun. 1997, 1685-1686. b) Collman, J.P.; Wang, Z.; Straumanis, A. J. Org. Chem. 1998, 63, 2424-2425.
18. 12 Dangles, O.; Guibé, F.; Balavoine, G. J. Org. Chem. 1987, 52, 4984-4993.
19. 13 a) Carell, T.; Wintner J. M.; Bashir-Hashemi, A.; Rebek, J., Jr. Angew. Chem. Ed. Engl. 1994, 33, 2059-2061.
20. b) Carell, T.; Wintner J. M.; Rebek, J., Jr. Angew. Chem. Ed. Engl. 1994, 33, 2061-2064.
21. c) Carell, T. et al. Chem. Biol. 1995, 2, 171-183.
22. d) Shipps, G. W.; Jr., Spitz, U. P.; Rebek, J., Jr. Bioorg. Med. Chem. 1996, 4, 655-657.
23. e) Pryor, K. E.; Shipps, G. W., Jr.; Skyler, D. A.; Rebek, J., Jr. Tetrahedron 1998, 54, 4107-4124.
24. 14 Bodansky, M., Principles of Peptide Synthesis 2nd Edition. Springer, Berlin Heidelberg New York, p 202.
25. 15 The amines used were: 4-Methoxybenzylamine, isobutylamine and H-Ala(OMe)*HCl.
26. 16 The acid chlorides used were: Phenylacetyl chloride, acetyl chloride and 3,5-dichlorobenzoyl chloride.
27. 17 The sulfonyl chlorides used were: Tosyl chloride, mesyl chloride and 4-nitrobenzenesulfonyl chloride.
28. 18 Zhang, L.; Kauffmann, G. S.; Pesti, J. A.; Yin, J. J. Org. Chem. 1997, 62, 6918-6920.
29. 19 a) Moore, S.; Patel, R. P.; Atherton, E.; Kondo, M.; Meienhofer, J. J. Med. Chem. 1976, 19(6), 766-772.
30. b) Ruan, F.; Chen, Y.; Itoh, K.; Sasaki, T.; Hopkins, P. B. J. Org. Chem. 1991, 56, 4347-4354.
31. c) Kunz, H.; Untervagt, C. Angew. Chem. Int. Ed. Engl. 1984, 23, 436.